Ling Wang

1PUBLICATIONS
1CO-AUTHORS
Solid tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

|Jun 10, 2022
Therapy of genomic unstable solid tumours (WHO grade 3/4）in clinical stage III/IV using individualised neoantigen tumour peptides-INP trial (individualised neoantigen tumour peptides immunotherapy): study protocol for an open-label, non-randomised, prospective, single-arm trial.

Ling Wang, Jiaxi Tang, Xia Chen

Pageof 1

Frequent Collaborators

1 joint publications

Jiaxi Tang